CCCC
Price
$2.29
Change
-$0.13 (-5.37%)
Updated
Jul 24 closing price
Capitalization
171.84M
12 days until earnings call
PHAT
Price
$9.05
Change
+$0.48 (+5.60%)
Updated
Jul 24 closing price
Capitalization
631.82M
13 days until earnings call
Interact to see
Advertisement

CCCC vs PHAT

Header iconCCCC vs PHAT Comparison
Open Charts CCCC vs PHATBanner chart's image
C4 Therapeutics
Price$2.29
Change-$0.13 (-5.37%)
Volume$1.15M
Capitalization171.84M
Phathom Pharmaceuticals
Price$9.05
Change+$0.48 (+5.60%)
Volume$1.02M
Capitalization631.82M
CCCC vs PHAT Comparison Chart in %
Loading...
CCCC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PHAT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CCCC vs. PHAT commentary
Jul 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CCCC is a StrongBuy and PHAT is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 25, 2025
Stock price -- (CCCC: $2.29 vs. PHAT: $9.05)
Brand notoriety: CCCC and PHAT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CCCC: 82% vs. PHAT: 39%
Market capitalization -- CCCC: $171.84M vs. PHAT: $631.82M
CCCC [@Biotechnology] is valued at $171.84M. PHAT’s [@Biotechnology] market capitalization is $631.82M. The market cap for tickers in the [@Biotechnology] industry ranges from $309.36B to $0. The average market capitalization across the [@Biotechnology] industry is $2.56B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CCCC’s FA Score shows that 1 FA rating(s) are green whilePHAT’s FA Score has 0 green FA rating(s).

  • CCCC’s FA Score: 1 green, 4 red.
  • PHAT’s FA Score: 0 green, 5 red.
According to our system of comparison, CCCC is a better buy in the long-term than PHAT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CCCC’s TA Score shows that 6 TA indicator(s) are bullish while PHAT’s TA Score has 3 bullish TA indicator(s).

  • CCCC’s TA Score: 6 bullish, 4 bearish.
  • PHAT’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, CCCC is a better buy in the short-term than PHAT.

Price Growth

CCCC (@Biotechnology) experienced а +5.05% price change this week, while PHAT (@Biotechnology) price change was +8.77% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.05%. For the same industry, the average monthly price growth was +18.11%, and the average quarterly price growth was +28.55%.

Reported Earning Dates

CCCC is expected to report earnings on Oct 30, 2025.

PHAT is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (+6.05% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PHAT($632M) has a higher market cap than CCCC($172M). PHAT YTD gains are higher at: 11.453 vs. CCCC (-36.389). CCCC has higher annual earnings (EBITDA): -102.74M vs. PHAT (-272.12M). CCCC (215M) and PHAT (212M) have equal amount of cash in the bank . CCCC has less debt than PHAT: CCCC (64.4M) vs PHAT (204M). PHAT has higher revenues than CCCC: PHAT (81.9M) vs CCCC (39.8M).
CCCCPHATCCCC / PHAT
Capitalization172M632M27%
EBITDA-102.74M-272.12M38%
Gain YTD-36.38911.453-318%
P/E RatioN/AN/A-
Revenue39.8M81.9M49%
Total Cash215M212M101%
Total Debt64.4M204M32%
TECHNICAL ANALYSIS
Technical Analysis
CCCCPHAT
RSI
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
80%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
86%
Momentum
ODDS (%)
Bullish Trend 1 day ago
79%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bullish Trend 1 day ago
83%
Bearish Trend 1 day ago
87%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
82%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
85%
Bearish Trend 1 day ago
87%
Advances
ODDS (%)
Bullish Trend 8 days ago
83%
Bullish Trend 1 day ago
84%
Declines
ODDS (%)
Bearish Trend 4 days ago
89%
Bearish Trend 8 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
81%
Bullish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
77%
Bearish Trend 1 day ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
CCCC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PHAT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TCKRF36.763.26
+9.73%
Teck Resources Ltd.
BRYGF0.01N/A
N/A
Baroyeca Gold & Silver, Inc.
CITAF0.15N/A
N/A
Cosco Shipping Development Co Ltd.
ZGXNF3.11N/A
N/A
Zigexn Co Ltd.
BTQNF38.85-0.23
-0.59%
BQE Water, Inc.

CCCC and

Correlation & Price change

A.I.dvisor indicates that over the last year, CCCC has been loosely correlated with BEAM. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if CCCC jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CCCC
1D Price
Change %
CCCC100%
-5.37%
BEAM - CCCC
54%
Loosely correlated
-5.46%
CRBU - CCCC
51%
Loosely correlated
-4.44%
PRME - CCCC
51%
Loosely correlated
-6.25%
IDYA - CCCC
50%
Loosely correlated
+5.08%
KYMR - CCCC
50%
Loosely correlated
-1.25%
More